Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/103782
Citations
Scopus Web of Science® Altmetric
?
?
Type: Journal article
Title: Cabozantinib inhibits abiraterone's upregulation of IGFIR phosphorylation and enhances its anti-prostate cancer activity
Author: Wang, X.
Huang, Y.
Christie, A.
Bowden, M.
Lee, G.
Kantoff, P.
Sweeney, C.
Citation: Clinical Cancer Research, 2015; 21(24):5578-5587
Publisher: American Association for Cancer Research
Issue Date: 2015
ISSN: 1078-0432
1557-3265
Statement of
Responsibility: 
Xiaodong Wang, Ying Huang, Amanda Christie, Michaela Bowden, Gwo-Shu Mary Lee, Philip W. Kantoff and Christopher J. Sweeney
Abstract: Abstract not available
Keywords: Cell Line, Tumor
Animals
Humans
Mice
Prostatic Neoplasms
Disease Models, Animal
Anilides
Pyridines
Androstenes
Receptor Protein-Tyrosine Kinases
Receptor, IGF Type 1
Receptors, Androgen
Antineoplastic Agents
Tumor Burden
Xenograft Model Antitumor Assays
Signal Transduction
Cell Proliferation
Phosphorylation
Drug Antagonism
Drug Resistance, Neoplasm
Male
Rights: © 2015 American Association for Cancer Research
DOI: 10.1158/1078-0432.CCR-15-0824
Appears in Collections:Aurora harvest 7
Medicine publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.